TLSA tizianalifesciences.com: Bozor qiymatining balans qiymatiga nisbati
Tiziana Life Sciences (TLSA) kompaniyasining baholash asosi neyroimmun patologiyaga qarshi kurashish uchun burun orqali antitanachalar yuborish sohasidagi patentlarga asoslangan bo'lib, bu -39.65 darajasidagi aksiya narxlarining retrospektivasi bilan tasdiqlanadi. Biznes ommaviy ishlab chiqarish davomida minimal xarajatlar bilan monoklonal dori vositalarini yaratishga tayanadi. Operatsion model partiya sintezi uchun GMP pudratchilaridan foydalanadi, bu esa ishlab chiqarish jadvaliga qat'iy rioya qilinishini va uzilishlarning yo'qligini ta'minlaydi.
Tiziana Life Sciences Ltd. (TLSA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Tiziana Life Sciences|TLSA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Tiziana Life Sciences PLC|TLSA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Tiziana Life Sciences PLC|TLSA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Tiziana Life Sciences|Tezkor likvidlik koeffitsiyenti tizianalifesciences.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Tiziana Life Sciences - TLSA
Noyob antitelalarni yetkazib berish tizimi uchun patentlarga egalik qilgan Tiziana Life Sciences (TLSA) narxlarni belgilash imkoniyatiga ega ekanligini ta'kidlamoqda, bu esa sof aktivlardan yuqori bo'lgan bozor qiymati premiumida aks etgan. Ushbu ko'rsatkich birja baholash qiymati va kapitalning balans qiymati o'rtasidagi farqni o'lchaydi; shuning uchun, joriy bozor qiymatining balans qiymatiga nisbati kompaniyaning intellektual mulkining kelgusidagi kapitalizatsiyasiga oid bozor kutganlarini namoyish etadi.
Raqobatchilar tahlili
ARGX: Bozor kapitallashuvining balans qiymatiga nisbati|biontech.de (BNTX) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|RIGL: Kapitallashuvning sof aktivlarga nisbati|AnaptysBio Inc. - Bozor kapitallashuvining balans qiymatiga multiplikatori|ATXS: Bozor kapitallashuvining balans qiymatiga nisbati|ENGN - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati RAPT|Aerovate - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ACRS|Balans qiymatiga nisbatan bozor kapitallashuvi Kyverna Therapeutics, Inc|Bozor kapitallashuvining balans qiymatiga nisbati CABA (Cabaletta Bio, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati ventyxbio.com VTYX|THTX - Bozor qiymatining balans qiymatiga nisbati|AVTX (Avalo Therapeutics, Inc.) - Kapitallashuvning balans qiymatiga nisbati|ELDN: Bozor kapitallashuvining balans qiymatiga nisbati|Agenus, Inc (AGEN) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati CLYM|ZURA: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati aTyr Pharma (ATYR)|Bozor qiymatining balans qiymatiga nisbati ADAG (adagene.com)|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Balans qiymatiga nisbatan bozor kapitallashuvi Shattuck Labs Inc (STTK)|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi CNTB|IMUX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Atara Bio (ATRA)|Kapitallashuvning sof aktivlarga nisbati IFRX|XFOR: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Adicet Bio (ACET)|Balans qiymatiga nisbatan bozor kapitallashuvi celularity.com|Bozor kapitallashuvining balans qiymatiga nisbati INMB (INmune Bio)|BRNS - Kapitallashuvning sof aktivlarga nisbati|Kezar Life Sciences, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SAB Biotherapeutics Inc SABS|AKTX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Enlivex Therapeutics Ltd. (ENLV)|Bozor qiymatining balans qiymatiga nisbati Q32 Bio Inc|Kapitallashuvning balans qiymatiga nisbati GOVX (GeoVax Labs)|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Kapitallashuvning sof aktivlarga nisbati iBio Corporation IBIO|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|xtlbio.com (XTLB) - Bozor qiymatining balans qiymatiga koeffitsiyenti|BOLT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi HCW Biologics Inc. HCWB|APVO (aptevotherapeutics.com) - Kapitallashuvning sof aktivlarga nisbati|AIM: Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|Bozor qiymatining balans qiymatiga nisbati GRI|Bozor qiymatining balans qiymatiga nisbati XORTX Therapeutics (XRTX)|Balans qiymatiga nisbatan bozor kapitallashuvi Vyome Holdings Inc.|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|Bozor kapitallashuvining balans qiymatiga nisbati Indaptus Corp INDP|SCNI - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi CALI|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|Allakos - Balans qiymatiga nisbatan bozor qiymati|HOOK (HOOKIPA Pharma, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IGM Bio|Bozor qiymatining balans qiymatiga nisbati iTeos Therapeutics (ITOS)|OCEA (oceanbiomedical.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati TC BioPharm TCBP|THRD - Kapitallashuvning sof aktivlarga nisbati